Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $31.37
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 15, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 11, 26 | Dacier Paul T | officer: CAO, CLO and Secretary | F-InKind | 4,457 @ $37.09 | $165.3K |
Daily · Wilder smoothing
| Rosenblatt |
| maintain |
| Buy |
| Buy |
| Oct 15, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 13, 26 | Rosenblatt | maintain | Buy | Buy |
| Sep 22, 26 | Wedbush | maintain | Outperform | Outperform |
| Sep 9, 26 | Mizuho | maintain | Outperform | Outperform |
| Sep 9, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Sep 9, 26 | Needham | maintain | Buy | Buy |
| Sep 9, 26 | Rosenblatt | maintain | Buy | Buy |
| Aug 6, 26 | Rosenblatt | maintain | Buy | Buy |
| Sep 11, 26 |
| Singh Inder M |
| officer: CFO & COO |
| F-InKind |
| 6,272 @ $37.09 |
| $232.6K |
| Sep 11, 26 | De Masi Niccolo | director, officer: President and CEO | F-InKind | 16,121 @ $37.09 | $598.0K |
| Sep 10, 26 | Raymond John W | director, other: Special Advisor | S-Sale | 2,407 @ $37.21 | $89.56K |
| Aug 24, 26 | Baxter Timothy E | director | A-Award | 5,540 | — |
| Aug 24, 26 | Baxter Timothy E | director | 0 | — |
| Aug 24, 26 | Ball Eric R. | director | A-Award | 5,540 | — |
| Aug 24, 26 | Ball Eric R. | director | 0 | — |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 34.79 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 10.27 | Oscillator | Buy |
| Williams %R (14) | -91.18 | Oscillator | Buy |
| MACD (12, 26, 9) | -2.74 (Hist -0.73) | Oscillator | Strong Sell |
| Average Directional Index (14) | 28.97 (+DI 12.1 / -DI 30.4) | Trend | Strong Sell |
| EMA 20 | 35.66 | MA | Strong Sell |
| SMA 20 | 37.60 | MA | Strong Sell |
| EMA 50 | 38.72 | MA | Strong Sell |
| SMA 50 | 39.49 | MA | Strong Sell |
| SMA 200 | 42.50 | MA | Strong Sell |
FY2025 · 10-K disclosure
Stock news · updated daily
IonQ (IONQ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Forget the quantum computing pure plays -- Microsoft is in a unique position in this space.
IonQ and Rigetti use different technologies in their quantum computers. Rigetti generated $5.1 million in second-quarter sales, while IonQ produced $80.1 million.
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world's leading quantum platform and foundry, today announced that the company will release its financial results for the quarter ended September 30, 2026, on Thursday, Nov. 5, 2026, after the financial markets close. IonQ will host a conference call at 4:30 PM Eastern Time that same day to discuss its results and business outlook. The call will be accessible by telephone at 1-888-349-0106 (domestic) or 1-412-902-0131 (international). T.
IonQ's upcoming new product launch could create major business opportunities for it. IonQ would have to become a trillion-dollar company to be a millionaire-maker stock.
A pair of October deals at IonQ has turned the quantum computing pure play into a dilution story.
The quantum computing company's revenue grew 287% in the second quarter, but its operating losses still dwarf its sales. Through a series of acquisitions, IonQ has expanded into networking, cybersecurity, sensing, and chip manufacturing.
Redwire and SoundHound AI have the most realistic paths to doubling by 2028. IonQ and D-Wave Quantum look like the most speculative bets here because quantum computing may take years to reach commercial viability.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -0.29 | -0.33 | Miss -13.8% | $80.05M |
| May 6, 2026 | -0.46 | 2.07 | Beat 548.5% | $64.67M |
| Feb 25, 2026 | -0.48 | 1.93 | Beat 502.1% | $61.89M |
| Nov 5, 2025 | -0.44 | -3.58 | Miss -713.6% | $39.87M |
| Aug 6, 2025 | -0.13 | -0.70 | Miss -438.5% | $20.69M |
| May 7, 2025 | -0.26 | -0.14 | Beat 46.2% | $7.57M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Oct 16, 2026 | 2026-10-16 17:00:15 | View |
| 424B5 | Oct 14, 2026 | 2026-10-14 08:47:40 | View |
| 424B5 | Oct 14, 2026 | 2026-10-14 08:39:04 | View |
| 8-K | Oct 13, 2026 | 2026-10-13 06:03:04 | View |
| 25-NSE | Sep 30, 2026 | 2026-09-30 10:03:54 | View |
| 4 | Sep 15, 2026 | 2026-09-15 21:50:06 | View |
| 4 | Sep 15, 2026 | 2026-09-15 21:50:05 | View |
| 4 | Sep 15, 2026 | 2026-09-15 21:50:03 | View |
| 4 | Sep 11, 2026 | 2026-09-11 21:55:03 | View |
| 8-K | Sep 8, 2026 | 2026-09-08 07:40:15 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | IONQ | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -7.3x | -22.3x · sector 44.2x | Discount |
| Forward P/E (FY26E) | -24.7x | EPS est. -1.27 | Elevated |
| Price / Book | 3.5x | 7.7x | Discount |
| Price / Sales | 51.6x | 401.7x | Discount |
| EV / EBITDA | 6.3x | -22.3x | Discount |
| Return on equity | -39.3% | — | Weak |
| Gross margin | 36.3% | 21.6% | Above hist. |
| Debt / Equity | 0.02 | 0.02 | Conservative |
| Piotroski / Altman Z | 3/9 | Z 2.97 | Grey zone |
Discounted cash flow model